Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links
US FDA REJECTS OSTEOPOROSIS DRUG

 

US FDA rejects Pfizer's new osteoporosis drug

 

BY OUR PHARMA CORRESPONDENT

15 September,2005: The US Food and Drug Administration has issued a non-approvable letter to Pfizer's new osteoporosis therapy lasofoxifene.

Branded as Oporia, the drug is a selective estrogen receptor modulator for the prevention of osteoporosis. 

Pfizer said in an official communique that the company will be reviewing its submission with the FDA and considering various possible courses of action.

BY OUR PHARMA CORRESPONDENT

 

RELATED US FDA STORIES

All USFDA news

Dr Reddy's nizatidine generic gets FDA nod 20 Sep, 2005

Abbott’s prostate cancer drug Xinlay unapprovable: US FDA 15 Sep, 2005

US FDA rejects Pfizer's new osteoporosis drug 15 Sep, 2005

Epilepsy drug rufinamide: Eisai seeks US FDA nod 15 Sep, 2005

US FDA approves Takeda’s drug combo for type 2 diabetes

US FDA stalls Roche’ Accutane use in pregnancy

Novo Nordisk’s 24-hour acting insulin Levemir gets US FDA okay

US FDA approves Teva's generic for osteoporosis 

Barr, Teva get fexofenadine approvals from US FDA

Barr gets US FDA okay for clonazepam tabs

FDA tightens restrictions on acne drug

FDA okays acrylic lens for cataract patients 

USFDA’s recall overdrive creates panic among drug users

Roche gets USFDA approval for oral Xeloda

Glaxo applies for FDA approval for Flaurix

US FDA to decide on Plan B morning-after pill by Sept 1

Painkiller patch Duragesic under US FDA probe over patients deaths

Teva gets US FDA nod for mirtazapine anti-depressant 

FDA directs Palladone withdrawal

Zidovudine by Ranbaxy gets US FDA tentative nod

Guidant defibrillator recall: US FDA makes three classifications

AIDS drug stavudine by Aurobindo Pharma gets tentative US FDA

US FDA to source anti-HIV drugs from Indian firms

FDA warning on abortion drug Mifeprex (Mifepristone)

US FDA recalls Baxter’s intravenous pumps

US FDA grants tentative nod to Ranbaxy’s glimepiride

Barr, Teva get fexofenadine approvals from US FDA

Insomnia treatment: ROZEREM approved by FDA

US FDA grants fast track status for GSK’s HIV drug

Halozyme gets FDA nod for bladder cancer therapy

Ranbaxy gets US FDA nod for sumatriptan tabs

US FDA approval for Orchid's ceftriaxone vials

IVAX gets FDA okay for hydrochlorothiazide caps

Ranbaxy gets USFDA nod for glimepiride tabs

US FDA blocks sale of Pharmakon's illegal drugs

   Pharma Home

 

Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links

Latest updates    Contact Us - Feedback    About Us